• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 4 months ago by International Alliance.
      • This topic was modified 6 years, 4 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Robbie Caliste, UK

      Robbie Caliste, UK

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Ali Var, Turkey

      Ali Var, Turkey

    • Mahmood Anwar, UK

      Mahmood Anwar, UK

    • Ana Lilia Rodriguez, Mexico

      Ana Lilia Rodriguez, Mexico

    • Shaleen Latchman, Canada

      Shaleen Latchman, Canada

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Chirag Walia, India

      Chirag Walia, India
      ChiragWalia

    • Daniel Hare, USA

      Daniel Hare, USA

    • Chris McCauley, Canada

      Chris McCauley, Canada

    • Marcelo Farinelli, Brazil

      Marcelo Farinelli, Brazil

    • Mark Miller, UK

      Mark Miller, UK

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Liong Ting Ngu, Malaysia

      Liong Ting Ngu, Malaysia

    • Verónica Isabel Castro Molina, Argentina

      Verónica Isabel Castro Molina, Argentina

    • Lin Yong Yi, Taiwan

      Lin Yong Yi, Taiwan

    • Vincent Bourque, Canada

      Vincent Bourque, Canada
      vincent_bourque

    • Lineke Veenstra, Netherlands

      Lineke Veenstra, Netherlands

    • Alfredo Santos, Colombia

      Alfredo Santos, Colombia

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • Rosie Riley, USA

      Rosie Riley, USA

    • Claudia Cominetti, Italy

      Claudia Cominetti, Italy

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Margarita Pizarro, Argentina

      Margarita Pizarro, Argentina

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Anita Forte, USA

      Anita Forte, USA

    • Sharon Corosanite, USA

      Sharon Corosanite, USA

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Alex, Argentina

      Alex, Argentina

    • Cassio Fernando da Silva, Brazil

      Cassio Fernando da Silva, Brazil

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Jean Waters, UK

      Jean Waters, UK

    • Lombana, Spain

      Lombana, Spain

    • Lee Millard, England

      Lee Millard, England

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • John Dinon, Australia

      John Dinon, Australia

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • David Solomon, UK

      David Solomon, UK

    • Jon Newsome, USA

      Jon Newsome, USA

    • Dr. Janmejay Pradhan, India

      Dr. Janmejay Pradhan, India

    • Wendy Hendrickson, USA

      Wendy Hendrickson, USA

    • Malcolm Buck, Australia

      Malcolm Buck, Australia

    • Liam Dwyer, England

      Liam Dwyer, England

    • Dick Dayton, USA

      Dick Dayton, USA

    • Barry de Reuver, Netherlands

      Barry de Reuver, Netherlands

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login